
    
      This is a phase 1, randomized, double-blind, placebo-controlled, single and multiple oral
      dose study in healthy Caucasian and Japanese male participants.

      The study is composed of three parts, Single-dose Ascending Part, Food Effect Part and
      Multiple-dose Ascending Part. Single-dose Ascending Part and Multiple-dose Ascending Part are
      designed as a randomized, double-blind or open-label, placebo-controlled, sequential-cohort,
      ascending single or multiple oral dose study of TAK-114 or matched placebo. The Food Effect
      Part is designed as a randomized, open-label, 2-period crossover study of a single dose of
      TAK-114.
    
  